Literature DB >> 25903707

Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.

Michael A Fischer1,2, Nikolaos Kartalis3,4, Aristeidis Grigoriadis3,4, Louiza Loizou3,4, Per Stål5, Bertil Leidner3,4, Peter Aspelin3,4, Torkel B Brismar3,4.   

Abstract

PURPOSE: To evaluate the diagnostic performance of dynamic perfusion CT (P-CT) for detection of hepatocellular carcinoma (HCC) in the cirrhotic liver.
MATERIALS AND METHODS: Twenty-six cirrhotic patients (19 men, aged 69 ± 10 years) with suspicion of HCC prospectively underwent P-CT of the liver using the 4D spiral-mode (100/80 kV; 150/175mAs/rot) of a dual-source system. Two readers assessed: (1) arterial liver-perfusion (ALP), portal-venous liver-perfusion (PLP) and hepatic perfusion-index (HPI) maps alone; and (2) side-by-side with maximum-intensity-projections of arterial time-points (art-MIP) for detection of HCC using histopathology and imaging follow-up as standard of reference. Another reader quantitatively assessed perfusion maps of detected lesions.
RESULTS: A total of 48 HCCs in 21/26 (81%) patients with a mean size of 20 ± 10 mm were detected by histopathology (9/48, 19%) or imaging follow-up (39/48, 81%). Detection rates (Reader1/Reader2) of HPI maps and side-by-side analysis of HPI combined with arterial MIP were 92/88% and 98/96%, respectively. Positive-predictive values were 63/63% and 68/71%, respectively. A cut-off value of ≥85% HPI and ≥99% HPI yielded a sensitivity and specificity of 100%, respectively, for detection of HCC.
CONCLUSION: P-CT shows a high sensitivity for detection of HCC in the cirrhotic liver. Quantitative assessment has the potential to reduce false-positive findings improving the specificity of HCC diagnosis. KEY POINTS: • Visual analysis of perfusion maps shows good sensitivity for detection of HCC. • Additional assessment of anatomical arterial MIPs further improves detection rates of HCC. • Quantitative perfusion analysis has the potential to reduce false-positive findings. • In cirrhotic livers, a hepatic-perfusion-index ≥ 9 9% might be specific for HCC.

Entities:  

Keywords:  Arterialized pseudolesion; Computed tomography; Hepatocellular carcinoma; Liver cirrhosis; Perfusion imaging

Mesh:

Substances:

Year:  2015        PMID: 25903707     DOI: 10.1007/s00330-015-3732-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Evaluation of a method for improving the detection of hepatocellular carcinoma.

Authors:  Edgar Bendik; Peter B Noël; Daniela Münzel; Alexander A Fingerle; Martin Henninger; Christian Markus; Alain Vlassenbroek; Ernst J Rummeny; Martin Dobritz
Journal:  Eur Radiol       Date:  2013-09-03       Impact factor: 5.315

2.  Influence of liver cirrhosis on pseudolesions in liver at CT during arterial portography.

Authors:  T Irie; Y Tsushima; S Terahata; K Hatsuse; S Kusano
Journal:  J Comput Assist Tomogr       Date:  1996 Nov-Dec       Impact factor: 1.826

3.  Time-resolved computed tomography of the liver: retrospective, multi-phase image reconstruction derived from volumetric perfusion imaging.

Authors:  Michael A Fischer; Bertil Leidner; Nikolaos Kartalis; Anders Svensson; Peter Aspelin; Nils Albiin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2013-08-31       Impact factor: 5.315

4.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

Authors:  Rita Golfieri; Matteo Renzulli; Vincenzo Lucidi; Beniamino Corcioni; Franco Trevisani; Luigi Bolondi
Journal:  Eur Radiol       Date:  2011-02-05       Impact factor: 5.315

Review 5.  Perfusion imaging in liver MRI.

Authors:  Choon Hua Thng; Tong San Koh; David Collins; Dow-Mu Koh
Journal:  Magn Reson Imaging Clin N Am       Date:  2014-08       Impact factor: 2.266

6.  Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination.

Authors:  Injoong Kim; Myeong-Jin Kim
Journal:  Korean J Radiol       Date:  2012-08-28       Impact factor: 3.500

7.  Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.

Authors:  Tatsuo Inoue; Tomoko Hyodo; Takamichi Murakami; Yukihisa Takayama; Akihiro Nishie; Atsushi Higaki; Keiko Korenaga; Azusa Sakamoto; Yukio Osaki; Hiroshi Aikata; Kazuaki Chayama; Takeshi Suda; Toru Takano; Kennichi Miyoshi; Masahiko Koda; Kazushi Numata; Hironori Tanaka; Hiroko Iijima; Hironori Ochi; Masashi Hirooka; Yasuharu Imai; Masatoshi Kudo
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

8.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging.

Authors:  Michele Di Martino; Gianmaria De Filippis; Adriano De Santis; Daniel Geiger; Maurizio Del Monte; Concetta Valentina Lombardo; Massimo Rossi; Stefano Ginanni Corradini; Gianluca Mennini; Carlo Catalano
Journal:  Eur Radiol       Date:  2012-11-18       Impact factor: 5.315

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  17 in total

1.  Dual-energy CT: a phantom comparison of different platforms for abdominal imaging.

Authors:  Thorsten Sellerer; Peter B Noël; Manuel Patino; Anushri Parakh; Sebastian Ehn; Sascha Zeiter; Jasmin A Holz; Johannes Hammel; Alexander A Fingerle; Franz Pfeiffer; David Maintz; Ernst J Rummeny; Daniela Muenzel; Dushyant V Sahani
Journal:  Eur Radiol       Date:  2018-02-05       Impact factor: 5.315

2.  Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.

Authors:  Michael A Fischer; Katharina Brehmer; Anders Svensson; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-02-25       Impact factor: 5.315

Review 3.  [CT and MRI of the liver: when, what, why?]

Authors:  J Budjan; S O Schoenberg; U I Attenberger
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

4.  Liver CT perfusion: which is the relevant delay that reduces radiation dose and maintains diagnostic accuracy?

Authors:  Alessandro Bevilacqua; Silvia Malavasi; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2019-05-21       Impact factor: 5.315

Review 5.  Updates on Imaging of Liver Tumors.

Authors:  Arya Haj-Mirzaian; Ana Kadivar; Ihab R Kamel; Atif Zaheer
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

6.  Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.

Authors:  Michael A Fischer; Herman P Marquez; Sonja Gordic; Bertil Leidner; Ernst Klotz; Peter Aspelin; Hatem Alkadhi; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-07-01       Impact factor: 5.315

7.  The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.

Authors:  Kuan-Chieh Fang; Chien-Wei Su; Yi-You Chiou; Pei-Chang Lee; Nai-Chi Chiu; Chien-An Liu; Ping-Hsien Chen; Wei-Yu Kao; Yi-Hsiang Huang; Teh-Ia Huo; Ming-Chih Hou; Han-Chieh Lin; Jaw-Ching Wu
Journal:  Eur Radiol       Date:  2016-09-27       Impact factor: 5.315

8.  Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Po-Chin Liang; Chiun Hsu; Chih-Hung Hsu; Ann-Lii Cheng; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2016-12-12       Impact factor: 5.315

Review 9.  The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma.

Authors:  Kang Liu; Xu-Li Min; Juan Peng; Ke Yang; Lin Yang; Xiao-Ming Zhang
Journal:  J Clin Med Res       Date:  2016-02-27

10.  Comparison of organ-specific-radiation dose levels between 70 kVp perfusion CT and standard tri-phasic liver CT in patients with hepatocellular carcinoma using a Monte-Carlo-Simulation-based analysis platform.

Authors:  J Gawlitza; H Haubenreisser; M Meyer; C Hagelstein; S Sudarski; S O Schoenberg; T Henzler
Journal:  Eur J Radiol Open       Date:  2016-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.